Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Aho, L.S.
Fascia, P.
and
Gisselmann, A.
1995.
L'impact socio-économique des entorses de cheville peut-il être évalué ?.
Réanimation Urgences,
Vol. 4,
Issue. 4,
p.
553.
BODGER, K.
DALY, M. J.
HEATLEY, R. V.
and
WILLIAMS, D. R. R.
1996.
Clinical Economics Review: gastroenterology.
Alimentary Pharmacology & Therapeutics,
Vol. 10,
Issue. 1,
p.
55.
Johannesson, Magnus
1996.
Theory and Methods of Economic Evaluation of Health Care.
Vol. 4,
Issue. ,
p.
47.
Johannesson, Magnus
1996.
The willingness to pay for health changes, the human-capital approach and the external costs.
Health Policy,
Vol. 36,
Issue. 3,
p.
231.
Cohen, Eric A.
and
Schwartz, Leonard
1996.
Coronary artery stenting: Indications and cost implications.
Progress in Cardiovascular Diseases,
Vol. 39,
Issue. 2,
p.
83.
Aho, L.S.
Fascia, P.
and
Gisselmann, A.
1996.
Les malaises, problème de santé publique — Retentissement économique.
Réanimation Urgences,
Vol. 5,
Issue. 4,
p.
598.
Johannesson, Magnus
Meltzer, David
and
O'Conor, Richard M.
1997.
Incorporating Future Costs in Medical Cost-Effectiveness Analysis.
Medical Decision Making,
Vol. 17,
Issue. 4,
p.
382.
Johannesson, Magnus
and
Karlsson, Göran
1997.
The friction cost method: A comment.
Journal of Health Economics,
Vol. 16,
Issue. 2,
p.
249.
Brunetti, M.
Pagano, E.
and
Garattini, L.
1998.
The economic cost of epilepsy: a review.
The Italian Journal of Neurological Sciences,
Vol. 19,
Issue. 2,
p.
116.
Tang, Jun
Wang, Baoguo
White, Paul F.
Watcha, Mehernoor F.
Qi, Jinhui
and
Wender, Ronald H.
1998.
The Effect of Timing of Ondansetron Administration on Its Efficacy, Cost-Effectiveness, and Cost-Benefit as a Prophylactic Antiemetic in the Ambulatory Setting.
Anesthesia & Analgesia,
Vol. 86,
Issue. 2,
p.
274.
Tang, Jun
Wang, Baoguo
White, Paul F.
Watcha, Mehernoor F.
Qi, Jinhui
and
Wender, Ronald H.
1998.
The Effect of Timing of Ondansetron Administration on Its Efficacy, Cost-Effectiveness, and Cost-Benefit as a Prophylactic Antiemetic in the Ambulatory Setting.
Anesthesia & Analgesia,
Vol. 86,
Issue. 2,
p.
274.
Lavayssière, Robert
and
Cabée, Anne-Elizabeth
1998.
Le marché mondial de l'imagerie médicale.
Annales de l'Institut Pasteur / Actualités,
Vol. 9,
Issue. 1,
p.
83.
Meltzer, David
and
Johannesson, Magnus
1999.
Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine.
Medical Decision Making,
Vol. 19,
Issue. 4,
p.
371.
Matthews, Debora C.
Sci, Dipl Periodont
Birch, Stephen
Gafni, Amiram
and
DiCenso, Alba
1999.
Willingness to Pay for Periodontal Therapy: Development and Testing of an Instrument.
Journal of Public Health Dentistry,
Vol. 59,
Issue. 1,
p.
44.
Heaney, D.C
Sander, J.W.A.S
and
Shorvon, S.D
2001.
Comparing the cost of epilepsy across eight European countries.
Epilepsy Research,
Vol. 43,
Issue. 2,
p.
89.
Eichler, Hans-Georg
Kong, Sheldon X.
Gerth, William C.
Mavros, Panagiotis
and
Jönsson, Bengt
2004.
Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?.
Value in Health,
Vol. 7,
Issue. 5,
p.
518.
Boos, Norbert
2009.
The impact of economic evaluation on quality management in spine surgery.
European Spine Journal,
Vol. 18,
Issue. S3,
p.
338.
Undabeitia, J.
Torres-Bayona, S.
Samprón, N.
Arrázola, M.
Bollar, A.
Armendariz, M.
Torres, P.
Ruiz, I.
Caballero, M.C.
Egaña, L.
Querejeta, A.
Villanua, J.
Pardo, E.
Etxegoien, I.
Liceaga, G.
Urtasun, M.
Michan, M.
Emparanza, J.I.
Aldaz, P.
Matheu, A.
and
Úrculo, E.
2018.
Indirect costs associated with glioblastoma: Experience at one hospital.
Neurología (English Edition),
Vol. 33,
Issue. 2,
p.
85.
Undabeitia, J.
Torres-Bayona, S.
Samprón, N.
Arrázola, M.
Bollar, A.
Armendariz, M.
Torres, P.
Ruiz, I.
Caballero, M.C.
Egaña, L.
Querejeta, A.
Villanua, J.
Pardo, E.
Etxegoien, I.
Liceaga, G.
Urtasun, M.
Michan, M.
Emparanza, J.I.
Aldaz, P.
Matheu, A.
and
Úrculo, E.
2018.
Costes indirectos asociados al glioblastoma. Experiencia en un centro.
Neurología,
Vol. 33,
Issue. 2,
p.
85.
Landfeldt, Erik
Zethraeus, Niklas
and
Lindgren, Peter
2019.
Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method.
Applied Health Economics and Health Policy,
Vol. 17,
Issue. 1,
p.
15.